Diabetes

KOL levels of expertise in each and every area

Charité Research Organisation is working across the widest possible range of therapeutic areas. By collaborating with Charité - Universitätsmedizin Berlin experts and KOLs, CRO is able to access and provide specialist expertise in each and every area of medicine.

Charité Research Organisation has undertaken multiple early clinical studies in diabetes, specifically type 2 diabetes. This has included First Time in Human, Phase I and POC studies in T2D patients who are treated by metformin alone and patients who are treated by metformin in combination with other classes such as DPP-4 inhibitors.
Inclusion of treatment naïve patients (and pre-diabetes subjects) may also be possible. Early clinical studies in type 1 diabetes patients are also possible. Capabilities include oral glucose tolerance testing and continual glucose monitoring. Glucose clamp is possible in collaboration with the Charité Departments of Endocrinology and Metabolism.

Company

Scientific Expertise

Operational Excellence

Recruitment

Value

Therapeutic Areas

KOL levels of expertise in each and every area

Diabetes